Stay updated on BION-1301 Study in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the BION-1301 Study in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BION-1301 Study in IgA Nephropathy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous v3.5.4. This marks a platform release update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-06-09T02:19:19.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A new publication reference added to the Publications section: Dulos J, Kreijtz J, Vink P, et al. Zigakibart Potently Inhibits A Proliferation-Inducing Ligand-Mediated IgA Production, Addressing IgAN Pathogenesis Root Causes. Kidney Int Rep. 2026 Apr 6;11(6):106516. This entry documents recent research related to Zigakibart and IgA nephropathy for readers.
    Difference
    0.0%
    Check dated 2026-06-02T00:26:54.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.5.3 to v3.5.4, indicating a new build of the page. This appears to be a minor maintenance update rather than a modification to the study content or user-facing details.
    Difference
    0.0%
    Check dated 2026-05-18T14:31:17.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer revision number was updated from v3.5.2 to v3.5.3, indicating a site version update without changing the study record details.
    Difference
    0.0%
    Check dated 2026-04-27T07:42:38.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T04:53:44.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Primary objective text updated to evaluate change in eGFR instead of proteinuria, and the protocol adds an exploratory cohort and an open-label extension. Remote visits to facilitate at-home administration, revised timelines, and an IPD data-sharing plan were also added.
    Difference
    1.0%
    Check dated 2026-04-05T16:59:11.000Z thumbnail image

Stay in the know with updates to BION-1301 Study in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BION-1301 Study in IgA Nephropathy Clinical Trial page.